Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka joins its Japanese peers on Twitter

The firm's US operations make their social media debut

Otsuka's US operations have joined Twitter, catching up with many of their Japanese peers.

Taking a practical approach to potential pitfalls with the medium the firm has compiled a straightforward set of Twitter guidelines and used as its pinned tweet details of how to report side effects.

Many of Otsuka's fellow Japanese pharma companies have been using Twitter for some time, with Daiichi Sankyo making the most extensive use with seven accounts, including ones for Europe, Spain and Brazil.

Astellas also makes wide use of the social media platform, with accounts that include its US corporate operations, a publications-based account and one for the cycling team it sponsors.

Takeda, meanwhile, is rather more focused, opting for a corporate account and one for the corporate communications team of its US oncology operations.

Some of the main Japanese pharma companies on Twitter

@AstellasUS
@AstellasPubs
@astellascycling
@AstellasINNOV8
@AstellasFDN
@AstellasCZ

@EUdaiichisankyo
@DaiichiSankyoES
@DaiichiSankyoJP
@DaiichiSankyoBr
@DaiichiSankyo
@DaiichiSankyoUK [Tweets protected]

@OtsukaUS

@TakedaPharma
@TakedaOncology

25th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics